Singapore News - BioNTech SE, the vaccine-maker that partnered Pfizer to produce the widely used Covid-19 shot, will be designating Singapore as its regional headquarters for South-east Asia. It also plans to set up a messenger RNA (mRNA) manufacturing facility here, which can be used to. Read more at www.tnp.sg
Share
BioNTech s Singapore office is expected to be operational in 2023 and will create at least 80 jobs. AFP
Vaccine maker BioNTech to set up regional HQ, manufacturing site in Singapore
Tue, 11 May 2021
BioNTech, the vaccine maker that has partnered with Pfizer on its Covid-19 shot, will be designating Singapore as its regional headquarters for Southeast Asia, and will set up an mRNA manufacturing facility in the city-state.
It plans to open its Singapore office and start the construction of the manufacturing facility this year, subject to planning approval. The site is expected to be operational in 2023 and will create at least 80 jobs, the German company said on May 10.
Publishing date: May 10, 2021 • 5 days ago • 2 minute read •
Article content
BERLIN BioNTech plans to set up a regional center and a new factory in Singapore for its vaccines, it said on Monday, boosting its presence in Asia as a debate over patents rages and pressure grows on drugmakers to raise output of COVID-19 shots.
Governments are looking to build up local vaccine production to secure access to supplies after manufacturing setbacks have slowed the rollout of COVID-19 doses in some countries.
We apologize, but this video has failed to load.
Try refreshing your browser, or BioNTech to build mRNA vaccine manufacturing site in Singapore Back to video
The Straits Times
Vaccine maker BioNTech to set up regional HQ, manufacturing site in S pore
BioNTech s Singapore office is expected to be operational in 2023 and will create at least 80 jobs.PHOTO: AFP
https://str.sg/JtKZ
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
Get unlimited access to all stories at $0.99/month for the first 3 months.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing .
BioNTech SEMay 10, 2021 GMT
BioNTech to establish first regional hub in Asia Pacific region in Singapore
Planned state-of-the-art manufacturing site will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for south east Asia against potential future pandemic threats
Expansion plan supported by the Singapore Economic Development Board (EDB)
MAINZ, GERMANY, May 10, 2021 BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans to expand its global footprint to Asia with the establishment of its Regional Headquarters for south east Asia in Singapore. In addition to selecting Singapore as its future regional headquarters, BioNTech plans to establish a fully integrated mRNA manufacturing facility in Singapore